The European Commission (EC) has approved argenx’s Vyvgart (efgartigimod alfa) subcutaneous (SC) injection to treat chronic inflammatory demyelinating polyneuropathy (CIDP). The drug, developed with ...
The concept of remote work isn’t new, but the advent and aftermath of Covid-19 accelerated employees’ adoption of the work-from-home model in a way that has significantly altered how we work.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback